Differences Between Cerebrovascular and Anti-Ischemic Effects of Dopamine, Docosahexaenoyldopamine, and GABA–Docosahexaenoyldopamine Conjugate

[1]  Roy A M Haast,et al.  Impact of fatty acids on brain circulation, structure and function. , 2015, Prostaglandins, leukotrienes, and essential fatty acids.

[2]  N. I. Avdyunina,et al.  Cerebrovascular and Neuroprotective Effects of Adamantane Derivative , 2014, BioMed research international.

[3]  C. Patch,et al.  DHA prevents altered 5-HT1A, 5-HT2A, CB1 and GABAA receptor binding densities in the brain of male rats fed a high-saturated-fat diet. , 2013, The Journal of nutritional biochemistry.

[4]  C. Tan.  Anticipatory changes in regional cerebral hemodynamics: a new role for dopamine? , 2009, Journal of neurophysiology.

[5]  B. Rosen,et al.  Inhibition of stimulated dopamine release and hemodynamic response in the brain through electrical stimulation of rat forepaw , 2008, Neuroscience Letters.

[6]  S. Wassall,et al.  Docosahexaenoic acid: membrane properties of a unique fatty acid. , 2003, Chemistry and physics of lipids.

[7]  Michelle Cook,et al.  Effects of Dopamine Receptor Blockade on Cerebral Blood Flow Response to Somatosensory Stimulation in the Unanesthetized Rat , 2002, Journal of Pharmacology and Experimental Therapeutics.

[8]  R. Traystman,et al.  Cerebrovascular effects of intravenous dopamine infusions in fetal sheep. , 2002, Journal of applied physiology.

[9]  D. Guilloteau,et al.  Polyunsaturated fatty acids and cerebral function: Focus on monoaminergic neurotransmission , 2001, Lipids.

[10]  J. Stamford,et al.  Effects of sevoflurane on dopamine, glutamate and aspartate release in an in vitro model of cerebral ischaemia. , 2001, British journal of anaesthesia.

[11]  T. Bisogno,et al.  Synthesis and biological evaluation of novel amides of polyunsaturated fatty acids with dopamine. , 2001, Bioorganic & medicinal chemistry letters.

[12]  N. Matsuki,et al.  Bidirectional actions of docosahexaenoic acid on hippocampal neurotransmissions in vivo , 2000, Brain Research.

[13]  P. Wood,et al.  Steroid inhibition of [3H]SR 95531 binding to the GABAA recognition site. , 1996, European journal of pharmacology.

[14]  B. Leonard,et al.  The dopamine agonists lisuride and piribedil protect against behavioural and histological changes following 4-vessel occlusion in the rat. , 1996, Neuropsychobiology.

[15]  J. Townsend,et al.  Pre- and Postsynaptic Neurotoxic Effects of Dopamine Demonstrated by Intrastriatal Injection , 1993, Experimental Neurology.

[16]  H. Fukuda,et al.  Characterization of antagonistic activity and binding properties of SR 95531, a pyridazinl‐GABA derivative, in rat brain and cultured cerebellar neuronal cells , 1992, Synapse.

[17]  R. Busto,et al.  Comparative Effect of Transient Global Ischemia on Extracellular Levels of Glutamate, Glycine, and γ‐Aminobutyric Acid in Vulnerable and Nonvulnerable Brain Regions in the Rat , 1991, Journal of neurochemistry.

[18]  R. Busto,et al.  Excitotoxic index — a biochemical marker of selective vulnerability , 1991, Neuroscience Letters.

[19]  P. H. Andersen.  The dopamine uptake inhibitor GBR 12909: selectivity and molecular mechanism of action , 1989 .

[20]  H. Miyake,et al.  Striatal dopamine in acute cerebral ischemia of stroke-resistant rats. , 1988, Stroke.